Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (361-370 of 506) with videos related to

Pageof 51
Sort By:
Presse Medicale (Paris, France : 1983)|July 17, 2014
Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working GroupDavid Launay, Laurent Savale, Alice Berezne, et al.
The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.
The Lancet. Rheumatology|November 22, 2025
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countriesEleana Bolla, Anne Grete Semb, Michelle Petri, et al.
RMD Open|January 4, 2024
History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosisClaire De Moreuil, Elizabeth Diot, Christian Agard, et al.
RMD Open|December 31, 2025
Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counsellingMichele Iudici, Zubeyir Salis, Pascal Cohen, et al.
Frontiers in Medicine|April 10, 2023
CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseasesKevin Chevalier, Michaël Genin, Thomas Petit Jean, et al.
Autoimmunity Reviews|October 18, 2017
Cogan syndrome: Characteristics, outcome and treatment in a French nationwide retrospective study and literature reviewCharlotte Durtette, Eric Hachulla, Matthieu Resche-Rigon, et al.
Arthritis Care & Research|July 9, 2016
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic TrialDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Blood|June 5, 2014
Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutationBaptiste Hervier, Julien Haroche, Laurent Arnaud, et al.
Pageof 51

Showing results (361-370 of 506) with videos related to

Sort By:
Pageof 51
Presse Medicale (Paris, France : 1983)|July 17, 2014
Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working GroupDavid Launay, Laurent Savale, Alice Berezne, et al.
The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.
The Lancet. Rheumatology|November 22, 2025
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countriesEleana Bolla, Anne Grete Semb, Michelle Petri, et al.
RMD Open|January 4, 2024
History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosisClaire De Moreuil, Elizabeth Diot, Christian Agard, et al.
RMD Open|December 31, 2025
Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counsellingMichele Iudici, Zubeyir Salis, Pascal Cohen, et al.
Frontiers in Medicine|April 10, 2023
CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseasesKevin Chevalier, Michaël Genin, Thomas Petit Jean, et al.
Autoimmunity Reviews|October 18, 2017
Cogan syndrome: Characteristics, outcome and treatment in a French nationwide retrospective study and literature reviewCharlotte Durtette, Eric Hachulla, Matthieu Resche-Rigon, et al.
Arthritis Care & Research|July 9, 2016
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic TrialDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Blood|June 5, 2014
Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutationBaptiste Hervier, Julien Haroche, Laurent Arnaud, et al.
Pageof 51